New Orleans, LANCT05266898Now EnrollingIRB Ready

Papillomavirus Vaccines Clinical Trial in New Orleans, LA

Access cutting-edge papillomavirus vaccines treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.

Sponsored by Louisiana State University Health Sciences Center in New Orleans

Quick Self-Assessment

See if you qualify for this New Orleans location

Preparing your pre-screening questions…

Expert Care in New Orleans

Access papillomavirus vaccines specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related papillomavirus vaccines treatment provided free

Apply for This New Orleans Location

Check if you qualify for this papillomavirus vaccines clinical trial in New Orleans, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Orleans

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Orleans site if eligible
  4. 4Begin participation

About This Papillomavirus Vaccines Study in New Orleans

The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adults with well-controlled HIV infection. The secondary objectives of the study are to observe short term clinical outcomes of prevalent HPV genotype-specific anogenital infections in adults living with HIV who complete the three-dose Gardasil-9 vaccine series, and to determine the protection afforded by Gardasil vaccine over time in previously vaccinated adults living with HIV. The clinical hypothesis is that adults with virologically controlled HIV mount a serum antibody response to the nonavalent HPV vaccine that is comparable to HIV negative counterparts. We also postulate that HPV vaccination will provide short-term clinical benefit against HPV infections and disease associated with vaccine genotypes and continuing protection against vaccine genotypes of HPV over time.

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Who Can Participate

Inclusion Criteria

HIV seropositive
immune intact (CD4+ T cell count in peripheral blood \>200 cells/ml)
HIV controlled (peripheral blood HIV viral load \<1,000 genome copies/mL)
Stable on antiretroviral regimen for ≥3 months
Gardasil-9 naive and age ≤45 OR
documented receipt of 3 doses of Gardasil-4 or Gardasil-9 HPV vaccine

Exclusion Criteria

Medical contraindication for vaccination (vaccine-naive arm only)
Women who are pregnant
Acute illness
Taking chronic steroids, \>0.5mg/kg prednisone or equivalent
Taking immune modulating medications
Received blood transfusion/blood products within the past 6 months
Recipients of other vaccine products within the past month
Inability to provide informed written consent

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Orleans?

Yes, this clinical trial (NCT05266898) has an active research site in New Orleans, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Papillomavirus Vaccines Treatment Options in New Orleans, LA

If you're searching for papillomavirus vaccines treatment options in New Orleans, LA, this clinical trial (NCT05266898) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced papillomavirus vaccines specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all papillomavirus vaccines clinical trials near you to find additional studies recruiting in your area.

More Vaccine Trials in New Orleans, LA

See all vaccine clinical trials recruiting in New Orleans — not just this study.

Browse Vaccine Trials in New Orleans

Browse More Trials by Condition

Ready to Join in New Orleans?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Orleans, LA